{
    "hands_on_practices": [
        {
            "introduction": "In the acute management of upper gastrointestinal bleeding, rapid and accurate risk stratification is crucial for guiding clinical decisions. This exercise  provides hands-on practice with the Glasgow-Blatchford score (GBS), a validated tool that synthesizes key laboratory and clinical parameters. By applying the GBS, you will learn to quantify a patient's risk for adverse outcomes, a fundamental skill for determining the appropriate level of care and urgency of intervention.",
            "id": "4883105",
            "problem": "A hospitalized adult with presumed peptic ulcer hemorrhage due to Helicobacter pylori presents for risk stratification to guide urgent management decisions. Risk stratification in upper gastrointestinal bleeding is built on physiologic derangements in perfusion and oxygen-carrying capacity, and on clinical features of bleeding severity, using validated tools such as the Glasgow-Blatchford score (GBS). The Glasgow-Blatchford score (GBS) assigns points across domains and sums them to a single integer; higher values reflect increased likelihood of needing intervention. Consider a female patient with the following findings at presentation: hemoglobin $Hb = 9\\,\\mathrm{g/dL}$, blood urea nitrogen $BUN = 30\\,\\mathrm{mg/dL}$, systolic blood pressure $SBP = 95\\,\\mathrm{mmHg}$, melena present, syncope absent, heart rate $HR = 110\\,\\mathrm{bpm}$, and no known hepatic disease or cardiac failure.\n\nUse the following standard point allocations for the Glasgow-Blatchford score (GBS). For blood urea nitrogen measured in $\\mathrm{mg/dL}$: \n- $18.2 \\le BUN \\le 22.3 \\rightarrow 2$ points, \n- $22.4 \\le BUN \\le 27.9 \\rightarrow 3$ points, \n- $28.0 \\le BUN \\le 69.9 \\rightarrow 4$ points, \n- $BUN \\ge 70.0 \\rightarrow 6$ points. \n\nFor hemoglobin measured in $\\mathrm{g/dL}$, sex-specific thresholds apply:\n- Women: $10.0 \\le Hb \\le 11.9 \\rightarrow 1$ point; $Hb < 10.0 \\rightarrow 6$ points.\n- Men: $12.0 \\le Hb \\le 12.9 \\rightarrow 1$ point; $10.0 \\le Hb \\le 11.9 \\rightarrow 3$ points; $Hb < 10.0 \\rightarrow 6$ points.\n\nFor systolic blood pressure measured in $\\mathrm{mmHg}$:\n- $100 \\le SBP \\le 109 \\rightarrow 1$ point; \n- $90 \\le SBP \\le 99 \\rightarrow 2$ points; \n- $SBP < 90 \\rightarrow 3$ points.\n\nFor pulse:\n- $HR \\ge 100\\,\\mathrm{bpm} \\rightarrow 1$ point.\n\nFor presentation:\n- Melena present $\\rightarrow 1$ point; \n- Syncope present $\\rightarrow 2$ points.\n\nFor comorbidity:\n- Hepatic disease present $\\rightarrow 2$ points; \n- Cardiac failure present $\\rightarrow 2$ points.\n\nCompute the total Glasgow-Blatchford score for this patient as the sum of the applicable points. Express your final answer as a single pure number with no units. No rounding is required.",
            "solution": "The problem is first validated.\n\n### Step 1: Extract Givens\nThe patient is a hospitalized adult female with presumed peptic ulcer hemorrhage. The data provided for risk stratification using the Glasgow-Blatchford score (GBS) are:\n- Patient sex: Female\n- Hemoglobin: $Hb = 9\\,\\mathrm{g/dL}$\n- Blood urea nitrogen: $BUN = 30\\,\\mathrm{mg/dL}$\n- Systolic blood pressure: $SBP = 95\\,\\mathrm{mmHg}$\n- Heart rate: $HR = 110\\,\\mathrm{bpm}$\n- Melena: present\n- Syncope: absent\n- Hepatic disease: no known\n- Cardiac failure: no known\n\nThe GBS point allocation rules are provided as follows:\n- For BUN (in $\\mathrm{mg/dL}$):\n  - $18.2 \\le BUN \\le 22.3 \\rightarrow 2$ points\n  - $22.4 \\le BUN \\le 27.9 \\rightarrow 3$ points\n  - $28.0 \\le BUN \\le 69.9 \\rightarrow 4$ points\n  - $BUN \\ge 70.0 \\rightarrow 6$ points\n- For Hemoglobin (in $\\mathrm{g/dL}$), for women:\n  - $10.0 \\le Hb \\le 11.9 \\rightarrow 1$ point\n  - $Hb < 10.0 \\rightarrow 6$ points\n- For Systolic Blood Pressure (in $\\mathrm{mmHg}$):\n  - $100 \\le SBP \\le 109 \\rightarrow 1$ point\n  - $90 \\le SBP \\le 99 \\rightarrow 2$ points\n  - $SBP < 90 \\rightarrow 3$ points\n- For Pulse:\n  - $HR \\ge 100\\,\\mathrm{bpm} \\rightarrow 1$ point\n- For Presentation:\n  - Melena present $\\rightarrow 1$ point\n  - Syncope present $\\rightarrow 2$ points\n- For Comorbidity:\n  - Hepatic disease present $\\rightarrow 2$ points\n  - Cardiac failure present $\\rightarrow 2$ points\n\n### Step 2: Validate Using Extracted Givens\nThe problem is scientifically grounded, well-posed, and objective. It describes a realistic clinical scenario and asks for the application of a standard, validated medical scoring system (GBS). All necessary data are provided, and the scoring rules are explicit and unambiguous. There are no contradictions, logical flaws, or scientifically unsound premises. The problem is a straightforward calculation based on a given set of rules and data.\n\n### Step 3: Verdict and Action\nThe problem is valid. A solution will be computed by applying the GBS scoring rules to the patient's data.\n\n### Solution Calculation\nThe total Glasgow-Blatchford score, denoted as $GBS_{total}$, is the sum of the points from each category. We will calculate the points for each component individually.\n\n1.  **Blood Urea Nitrogen (BUN) Score:**\n    The patient's $BUN$ is given as $30\\,\\mathrm{mg/dL}$. We refer to the scoring table for $BUN$. The patient's value falls into the range $28.0 \\le BUN \\le 69.9$, which corresponds to $4$ points.\n    Since $28.0 \\le 30 \\le 69.9$, the score for BUN is $S_{BUN} = 4$.\n\n2.  **Hemoglobin (Hb) Score:**\n    The patient is female, and her hemoglobin is $Hb = 9\\,\\mathrm{g/dL}$. The scoring rule for women with $Hb < 10.0\\,\\mathrm{g/dL}$ assigns $6$ points.\n    Since $9 < 10.0$, the score for hemoglobin is $S_{Hb} = 6$.\n\n3.  **Systolic Blood Pressure (SBP) Score:**\n    The patient's $SBP$ is $95\\,\\mathrm{mmHg}$. This value falls within the range $90 \\le SBP \\le 99$, which corresponds to $2$ points.\n    Since $90 \\le 95 \\le 99$, the score for SBP is $S_{SBP} = 2$.\n\n4.  **Other Clinical Markers Score:**\n    -   **Heart Rate (Pulse):** The patient's heart rate is $HR = 110\\,\\mathrm{bpm}$. The rule assigns $1$ point for $HR \\ge 100\\,\\mathrm{bpm}$. Since $110 \\ge 100$, the score for heart rate is $S_{HR} = 1$.\n    -   **Melena:** The patient presents with melena. This finding awards $1$ point. Thus, the score for melena is $S_{melena} = 1$.\n    -   **Syncope:** The patient does not have syncope. Points are only awarded if syncope is present. Therefore, the score for syncope is $S_{syncope} = 0$.\n    -   **Hepatic Disease:** The patient has no known hepatic disease. Points are only awarded if hepatic disease is present. Therefore, the score for hepatic disease is $S_{hepatic} = 0$.\n    -   **Cardiac Failure:** The patient has no known cardiac failure. Points are only awarded if cardiac failure is present. Therefore, the score for cardiac failure is $S_{cardiac} = 0$.\n\nThe total Glasgow-Blatchford score is the sum of the points from all components:\n$$ GBS_{total} = S_{BUN} + S_{Hb} + S_{SBP} + S_{HR} + S_{melena} + S_{syncope} + S_{hepatic} + S_{cardiac} $$\nSubstituting the calculated point values:\n$$ GBS_{total} = 4 + 6 + 2 + 1 + 1 + 0 + 0 + 0 $$\n$$ GBS_{total} = 14 $$\nThe total Glasgow-Blatchford score for this patient is $14$.",
            "answer": "$$\\boxed{14}$$"
        },
        {
            "introduction": "The efficacy of *Helicobacter pylori* eradication therapies is critically dependent on local antibiotic resistance patterns. This problem  challenges you to model this clinical reality by calculating the overall probability of treatment failure for concomitant quadruple therapy, considering independent resistance to both clarithromycin and metronidazole. Mastering this application of probability theory is essential for making informed, evidence-based decisions about first-line empirical treatment and for understanding the public health implications of rising antibiotic resistance.",
            "id": "4883124",
            "problem": "A population of patients with peptic ulcer disease due to Helicobacter pylori is treated with non-bismuth concomitant quadruple therapy comprising a proton pump inhibitor (PPI), amoxicillin, clarithromycin, and metronidazole. Let $R_C$ denote that the infecting Helicobacter pylori strain is resistant to clarithromycin and $R_M$ denote resistance to metronidazole. Assume $R_C$ and $R_M$ are independent. The prevalence of clarithromycin resistance is $15\\%$, so $P(R_C)=0.15$, and the prevalence of metronidazole resistance is $30\\%$, so $P(R_M)=0.30$. The observed per-patient cure probabilities under concomitant therapy are $92\\%$ if the strain is susceptible to both agents, $80\\%$ if the strain is resistant to exactly one of the two agents, and $60\\%$ if the strain is resistant to both agents. Using independence and the law of total probability, compute the overall probability of treatment failure in this population. Express the final probability as a decimal rounded to four significant figures.",
            "solution": "The problem is first validated for correctness and solvability.\n\n**Step 1: Extract Givens**\n- Let $R_C$ be the event that the infecting *Helicobacter pylori* strain is resistant to clarithromycin.\n- Let $R_M$ be the event that the infecting *Helicobacter pylori* strain is resistant to metronidazole.\n- The events $R_C$ and $R_M$ are independent.\n- The prevalence of clarithromycin resistance is $P(R_C) = 0.15$.\n- The prevalence of metronidazole resistance is $P(R_M) = 0.30$.\n- Let $C$ be the event of a cure.\n- The conditional probability of cure if the strain is susceptible to both clarithromycin and metronidazole is $P(C \\mid R_C^c \\cap R_M^c) = 0.92$.\n- The conditional probability of cure if the strain is resistant to exactly one of the two agents is $0.80$.\n- The conditional probability of cure if the strain is resistant to both agents is $P(C \\mid R_C \\cap R_M) = 0.60$.\n- The task is to compute the overall probability of treatment failure, $P(C^c)$.\n\n**Step 2: Validate Using Extracted Givens**\n- **Scientifically Grounded:** The problem describes a realistic scenario in clinical practice concerning antibiotic resistance and treatment outcomes for *H. pylori* eradication. The specified drugs, resistance prevalences, and cure rates are plausible.\n- **Well-Posed:** The problem provides all necessary data (probabilities and the independence assumption) to calculate a unique solution using standard probability theory.\n- **Objective:** The problem is stated in precise, quantitative terms, free from ambiguity or subjective claims.\n\n**Step 3: Verdict and Action**\n- The problem is valid as it is scientifically grounded, well-posed, and objective. A solution will be derived.\n\n**Solution Derivation**\n\nLet $R_C$ be the event of resistance to clarithromycin and $R_M$ be the event of resistance to metronidazole. Let $C$ denote the event of treatment cure. We are given the following probabilities:\n$$P(R_C) = 0.15$$\n$$P(R_M) = 0.30$$\nThe events $R_C$ and $R_M$ are independent. The probabilities of susceptibility (non-resistance), denoted by the complementary events $R_C^c$ and $R_M^c$, are:\n$$P(R_C^c) = 1 - P(R_C) = 1 - 0.15 = 0.85$$\n$$P(R_M^c) = 1 - P(R_M) = 1 - 0.30 = 0.70$$\n\nThe patient population can be partitioned into four mutually exclusive groups based on the resistance profile:\n1.  Susceptible to both agents ($S_{Both}$): The event $R_C^c \\cap R_M^c$.\n2.  Resistant to clarithromycin only ($R_{C,only}$): The event $R_C \\cap R_M^c$.\n3.  Resistant to metronidazole only ($R_{M,only}$): The event $R_C^c \\cap R_M$.\n4.  Resistant to both agents ($R_{Both}$): The event $R_C \\cap R_M$.\n\nBecause $R_C$ and $R_M$ are independent, their complements $R_C^c$ and $R_M^c$ are also independent. We can thus calculate the probability of each partition:\n$$P(S_{Both}) = P(R_C^c \\cap R_M^c) = P(R_C^c)P(R_M^c) = (0.85)(0.70) = 0.595$$\n$$P(R_{C,only}) = P(R_C \\cap R_M^c) = P(R_C)P(R_M^c) = (0.15)(0.70) = 0.105$$\n$$P(R_{M,only}) = P(R_C^c \\cap R_M) = P(R_C^c)P(R_M) = (0.85)(0.30) = 0.255$$\n$$P(R_{Both}) = P(R_C \\cap R_M) = P(R_C)P(R_M) = (0.15)(0.30) = 0.045$$\n\nThe problem provides the conditional probabilities of cure for each scenario:\n-   $P(C \\mid S_{Both}) = 0.92$\n-   $P(C \\mid R_{C,only}) = P(C \\mid R_{M,only}) = 0.80$\n-   $P(C \\mid R_{Both}) = 0.60$\n\nThe overall probability of cure, $P(C)$, can be calculated using the law of total probability, summing over the partition of the sample space:\n$$P(C) = P(C \\mid S_{Both})P(S_{Both}) + P(C \\mid R_{C,only})P(R_{C,only}) + P(C \\mid R_{M,only})P(R_{M,only}) + P(C \\mid R_{Both})P(R_{Both})$$\nSubstituting the respective values:\n$$P(C) = (0.92)(0.595) + (0.80)(0.105) + (0.80)(0.255) + (0.60)(0.045)$$\nLet's compute each term:\n$$P(C) = 0.5474 + 0.084 + 0.204 + 0.027$$\n$$P(C) = 0.8624$$\n\nThe question asks for the overall probability of treatment failure, which is the complement of the cure event, $P(C^c)$.\n$$P(C^c) = 1 - P(C)$$\n$$P(C^c) = 1 - 0.8624 = 0.1376$$\nThe problem requires the result as a decimal rounded to four significant figures. The calculated value $0.1376$ has exactly four significant figures.",
            "answer": "$$\n\\boxed{0.1376}\n$$"
        },
        {
            "introduction": "Effective and safe pharmacotherapy requires tailoring treatment to the individual patient's physiology, particularly their organ function. This exercise  focuses on the critical skill of renal dose adjustment for antibiotics commonly used in *H. pylori* eradication. You will use the Cockcroft-Gault equation to estimate a patient's creatinine clearance and apply this information to modify amoxicillin and clarithromycin doses, thereby preventing drug accumulation and potential toxicity while preserving therapeutic efficacy.",
            "id": "4883075",
            "problem": "A $68$-year-old non-obese female with peptic ulcer disease due to Helicobacter pylori is to begin triple therapy consisting of a proton pump inhibitor (PPI), amoxicillin, and clarithromycin. The intended baseline dosing (in the absence of renal impairment) is amoxicillin $1000 \\ \\mathrm{mg}$ every $12 \\ \\mathrm{h}$ and clarithromycin $500 \\ \\mathrm{mg}$ every $12 \\ \\mathrm{h}$. Her actual body weight is $52 \\ \\mathrm{kg}$, and her serum creatinine is $2.1 \\ \\mathrm{mg/dL}$. Assume steady-state creatinine production and use the Cockcroftâ€“Gault equation to estimate creatinine clearance (CrCl) for a female, taking actual body weight as appropriate for non-obese adults:\n$$\n\\mathrm{CrCl} = \\frac{(140 - \\text{age}) \\times \\text{weight}}{72 \\times \\text{serum creatinine}} \\times 0.85 \\quad \\text{in} \\ \\mathrm{mL/min}.\n$$\nApply the following widely accepted renal dosing rules for these antibiotics to prevent accumulation and toxicity:\n- Amoxicillin: if $10 \\le \\mathrm{CrCl} < 30$, use $500 \\ \\mathrm{mg}$ every $12 \\ \\mathrm{h}$; if $\\mathrm{CrCl} < 10$, use $500 \\ \\mathrm{mg}$ every $24 \\ \\mathrm{h}$; if $\\mathrm{CrCl} \\ge 30$, use $1000 \\ \\mathrm{mg}$ every $12 \\ \\mathrm{h}$.\n- Clarithromycin: if $\\mathrm{CrCl} < 30$, reduce each $500 \\ \\mathrm{mg}$ dose by $50\\%$ while maintaining the $12 \\ \\mathrm{h}$ interval; if $\\mathrm{CrCl} \\ge 30$, use $500 \\ \\mathrm{mg}$ every $12 \\ \\mathrm{h}$.\nUsing these principles and rules, compute the adjusted regimen and then determine the combined total daily antibiotic dose (amoxicillin plus clarithromycin) in milligrams for this patient after renal adjustment. Express your final answer as a single number in milligrams. If the final numerical result is not an exact integer, round your answer to four significant figures.",
            "solution": "The problem statement has been evaluated and is deemed valid. It is scientifically grounded in the principles of clinical pharmacology and pharmacokinetics, well-posed with sufficient and consistent data, and objectively stated. We may therefore proceed with the solution.\n\nThe problem requires a multi-step calculation to determine the correct total daily antibiotic dose for a patient with renal impairment. The steps are:\n1.  Calculate the patient's estimated creatinine clearance (CrCl) using the provided Cockcroft-Gault equation.\n2.  Use the calculated CrCl to determine the renally adjusted dose for amoxicillin based on the given rules.\n3.  Use the calculated CrCl to determine the renally adjusted dose for clarithromycin based on the given rules.\n4.  Calculate the total daily dose by summing the daily doses of both antibiotics.\n\nThe patient's data are as follows:\n- Age: $68$ years\n- Sex: female\n- Actual body weight: $52 \\ \\mathrm{kg}$\n- Serum creatinine (SCr): $2.1 \\ \\mathrm{mg/dL}$\n\nFirst, we calculate the creatinine clearance (CrCl) using the Cockcroft-Gault equation for a female patient, as specified:\n$$\n\\mathrm{CrCl} = \\frac{(140 - \\text{age}) \\times \\text{weight}}{72 \\times \\text{serum creatinine}} \\times 0.85\n$$\nSubstituting the patient's specific values:\n$$\n\\mathrm{CrCl} = \\frac{(140 - 68) \\times 52}{72 \\times 2.1} \\times 0.85\n$$\n$$\n\\mathrm{CrCl} = \\frac{72 \\times 52}{151.2} \\times 0.85\n$$\n$$\n\\mathrm{CrCl} = \\frac{3744}{151.2} \\times 0.85\n$$\n$$\n\\mathrm{CrCl} \\approx 24.7619... \\times 0.85\n$$\n$$\n\\mathrm{CrCl} \\approx 21.0476 \\ \\mathrm{mL/min}\n$$\nThe calculated creatinine clearance is approximately $21.05 \\ \\mathrm{mL/min}$.\n\nNext, we determine the adjusted amoxicillin dose. The dosing rules for amoxicillin are:\n- If $10 \\le \\mathrm{CrCl} < 30$, use $500 \\ \\mathrm{mg}$ every $12 \\ \\mathrm{h}$.\n- If $\\mathrm{CrCl} < 10$, use $500 \\ \\mathrm{mg}$ every $24 \\ \\mathrm{h}$.\n- If $\\mathrm{CrCl} \\ge 30$, use $1000 \\ \\mathrm{mg}$ every $12 \\ \\mathrm{h}$.\n\nSince our calculated $\\mathrm{CrCl}$ is $21.05 \\ \\mathrm{mL/min}$, it falls within the range $10 \\le \\mathrm{CrCl} < 30$. Therefore, the adjusted amoxicillin regimen is $500 \\ \\mathrm{mg}$ every $12$ hours. The total daily dose of amoxicillin, $D_{\\text{amox}}$, is:\n$$\nD_{\\text{amox}} = 500 \\ \\mathrm{mg/dose} \\times 2 \\ \\mathrm{doses/day} = 1000 \\ \\mathrm{mg/day}\n$$\n\nNow, we determine the adjusted clarithromycin dose. The dosing rules for clarithromycin are:\n- If $\\mathrm{CrCl} < 30$, reduce each $500 \\ \\mathrm{mg}$ dose by $50\\%$ while maintaining the $12 \\ \\mathrm{h}$ interval.\n- If $\\mathrm{CrCl} \\ge 30$, use $500 \\ \\mathrm{mg}$ every $12 \\ \\mathrm{h}$.\n\nSince our calculated $\\mathrm{CrCl}$ of $21.05 \\ \\mathrm{mL/min}$ is less than $30 \\ \\mathrm{mL/min}$, a dose reduction is required. The standard dose of $500 \\ \\mathrm{mg}$ must be reduced by $50\\%$.\nThe adjusted dose per administration is:\n$$\n500 \\ \\mathrm{mg} \\times (1 - 0.50) = 500 \\ \\mathrm{mg} \\times 0.50 = 250 \\ \\mathrm{mg}\n$$\nThis adjusted dose is administered every $12$ hours. The total daily dose of clarithromycin, $D_{\\text{clarith}}$, is:\n$$\nD_{\\text{clarith}} = 250 \\ \\mathrm{mg/dose} \\times 2 \\ \\mathrm{doses/day} = 500 \\ \\mathrm{mg/day}\n$$\n\nFinally, we compute the combined total daily antibiotic dose, $D_{\\text{total}}$, by summing the total daily doses of amoxicillin and clarithromycin.\n$$\nD_{\\text{total}} = D_{\\text{amox}} + D_{\\text{clarith}}\n$$\n$$\nD_{\\text{total}} = 1000 \\ \\mathrm{mg/day} + 500 \\ \\mathrm{mg/day} = 1500 \\ \\mathrm{mg/day}\n$$\nThe result is an exact integer, so no rounding is necessary. The combined total daily antibiotic dose is $1500 \\ \\mathrm{mg}$.",
            "answer": "$$\\boxed{1500}$$"
        }
    ]
}